Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Debt Ratio: 2019-2025

Historic Debt Ratio for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to 0.14.

  • Harmony Biosciences Holdings' Debt Ratio fell 29.21% to 0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14, marking a year-over-year decrease of 29.21%. This contributed to the annual value of 0.18 for FY2024, which is 24.79% down from last year.
  • Harmony Biosciences Holdings' Debt Ratio amounted to 0.14 in Q3 2025, which was down 10.21% from 0.16 recorded in Q2 2025.
  • Harmony Biosciences Holdings' Debt Ratio's 5-year high stood at 0.58 during Q1 2021, with a 5-year trough of 0.14 in Q3 2025.
  • Moreover, its 3-year median value for Debt Ratio was 0.22 (2024), whereas its average is 0.21.
  • Data for Harmony Biosciences Holdings' Debt Ratio shows a maximum YoY crashed of 39.33% (in 2022) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Debt Ratio (Quarterly) stood at 0.44 in 2021, then plummeted by 35.79% to 0.28 in 2022, then declined by 16.12% to 0.24 in 2023, then dropped by 24.79% to 0.18 in 2024, then dropped by 29.21% to 0.14 in 2025.
  • Its last three reported values are 0.14 in Q3 2025, 0.16 for Q2 2025, and 0.17 during Q1 2025.